Cite
Terry S, Dalban C, Rioux-Leclercq N, et al. Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade. Clin Cancer Res. 2021;27(24):6749-6760doi: 10.1158/1078-0432.CCR-21-0972.
Terry, S., Dalban, C., Rioux-Leclercq, N., Adam, J., Meylan, M., Buart, S., Bougoüin, A., Lespagnol, A., Dugay, F., Moreno, I. C., Lacroix, G., Lorens, J. B., Gausdal, G., Fridman, W. H., Mami-Chouaib, F., Chaput, N., Beuselinck, B., Chabaud, S., Barros-Monteiro, J., Vano, Y., Escudier, B., Sautès-Fridman, C., Albiges, L., & Chouaib, S. (2021). Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(24), 6749-6760. https://doi.org/10.1158/1078-0432.CCR-21-0972
Terry, Stéphane, et al. "Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,24 (2021): 6749-6760. doi: https://doi.org/10.1158/1078-0432.CCR-21-0972
Terry S, Dalban C, Rioux-Leclercq N, Adam J, Meylan M, Buart S, Bougoüin A, Lespagnol A, Dugay F, Moreno IC, Lacroix G, Lorens JB, Gausdal G, Fridman WH, Mami-Chouaib F, Chaput N, Beuselinck B, Chabaud S, Barros-Monteiro J, Vano Y, Escudier B, Sautès-Fridman C, Albiges L, Chouaib S. Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade. Clin Cancer Res. 2021 Dec 15;27(24):6749-6760. doi: 10.1158/1078-0432.CCR-21-0972. Epub 2021 Aug 18. PMID: 34407968.
Copy
Download .nbib